Stockreport

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (Nasdaq: SLN) (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transf [Read more]